Fly-E Group, Inc. Sued for Securities Law Violations – Investors Should Contact The Gross Law Firm Before November 10, 2025 to Discuss Your Rights – FLYE

(NASDAQ:FLYE), NEW YORK, Oct. 30, 2025 (GLOBE NEWSWIRE) — The Gross Law Firm issues the following notice to shareholders of Fly-E Group, Inc. (NASDAQ: FLYE). Shareholders who purchased shares of FLYE during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to […]

Fly-E Group, Inc. Sued for Securities Law Violations – Investors Should Contact The Gross Law Firm Before November 10, 2025 to Discuss Your Rights – FLYE

Fly-E Group, Inc. Sued for Securities Law Violations – Investors Should Contact The Gross Law Firm Before November 10, 2025 to Discuss Your Rights – FLYE GlobeNewswire October 30, 2025 NEW YORK, Oct. 30, 2025 (GLOBE NEWSWIRE) — The Gross Law Firm issues the following notice to shareholders of Fly-E Group, Inc. (NASDAQ: FLYE). Shareholders

LNTH Deadline: LNTH Investors Have Opportunity to Lead Lantheus Holdings, Inc. Securities Fraud Lawsuit

https://mma.prnewswire.com/media/405060/Rosen_Law_Logo.jpg Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Lantheus Holdings, Inc. (NASDAQ: LNTH) between February 26, 2025 and August 5, 2025, both dates inclusive (the “Class Period”), of the important November 10, 2025 lead plaintiff deadline. So what: If you purchased Lantheus securitiesduring the Class Period you

BCP Announces Sale of The Gray Casualty & Surety Company

BCP, a services and infrastructure-focused private equity management firm, today announced an agreement to sell The Gray Casualty & Surety Company (“Gray Surety”), a leading surety bond provider for midsized and emerging contractors, to Palomar Holdings, Inc. (NASDAQ: PLMR) (“Palomar”). The transaction has been approved by both Gray Surety and Palomar's boards of directors and

Cboe Announces JJ Kinahan to Lead Retail Market Expansion and Innovation Efforts

Cboe Global Markets, Inc. (Cboe: CBOE), the world's leading derivatives and securities exchange network, today announced JJ Kinahan will join as Senior Vice President, Head of Retail Expansion and Alternative Investment Products. https://mma.prnewswire.com/media/622233/Cboe_GM_New_Logo.jpg In this role, Mr. Kinahan will lead Cboe's newly established business vertical focused on developing alternative investment products for retail customers, helping

Certain roasted pistachios recalled due to Salmonella

Product: Roasted Pistachios Issue: Food – Microbial contamination – Salmonella Distribution:Quebec See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA) https://rt.newswire.ca/rt.gif?NewsItemId=C7833&Transmission_Id=202510301620CANADANWWEB______C7833&DateId=20251030

Minno Named Kids-First Streaming Partner for 5&2 Studios’ The Chosen Adventures

New Animated Series Based on Global Hit The Chosen Launches on Minno October 31, 2025 Minno, the global leader in Christian kids' streaming, has been named the faith-first, kids-first streaming partner for The Chosen Adventures, a new animated series produced by 5&2 Studios. The series is currently available on Prime Video and starts streaming onMinno

ROSEN, LEADING INVESTOR COUNSEL, Encourages aTyr Pharma, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ATYR

(NASDAQ:ATYR), NEW YORK, Oct. 30, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of aTyr Pharma, Inc. (NASDAQ: ATYR) between January 16, 2025 and September 12, 2025, both dates inclusive (the “Class Period”), of the important December 8, 2025 lead plaintiff deadline. SO WHAT:

ROSEN, LEADING INVESTOR COUNSEL, Encourages aTyr Pharma, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ATYR

ROSEN, LEADING INVESTOR COUNSEL, Encourages aTyr Pharma, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ATYR GlobeNewswire October 30, 2025 NEW YORK, Oct. 30, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of aTyr Pharma, Inc. (NASDAQ: ATYR) between

Artiva Biotherapeutics to Participate in Upcoming Investor Conferences in November

(NasdaqGM:ARTV), SAN DIEGO, Oct. 30, 2025 (GLOBE NEWSWIRE) — Artiva Biotherapeutics, Inc. (Nasdaq: ARTV), a clinical-stage biotechnology company whose mission is to develop effective, safe, and accessible cell therapies for patients with devastating autoimmune diseases and cancers, announced today that management will participate at the following investor conferences: TD Cowen's Immunology & Inflammation Summit (Virtual)

Scroll to Top